The increase in the levels of SASP and other factors and the decrease in the level of IGF-1 in the peripheral blood samples of breast cancer patients who had received chemotherapy indicated accelerated cerebrovascular aging, which led to the decline in cerebral cognition. The gene discussed is IGF1; the disease is breast cancer.